IGF-1 has sexually dimorphic, pleiotropic, and time-dependent effects on healthspan, pathology, and lifespan
- 13 April 2017
- journal article
- research article
- Published by Springer Science and Business Media LLC in GeroScience
- Vol. 39 (2), 129-145
- https://doi.org/10.1007/s11357-017-9971-0
Abstract
Reduced circulating levels of IGF-1 have been proposed as a conserved anti-aging mechanism that contributes to increased lifespan in diverse experimental models. However, IGF-1 has also been shown to be essential for normal development and the maintenance of tissue function late into the lifespan. These disparate findings suggest that IGF-1 may be a pleiotropic modulator of health and aging, as reductions in IGF-1 may be beneficial for one aspect of aging, but detrimental for another. We postulated that the effects of IGF-1 on tissue health and function in advanced age are dependent on the tissue, the sex of the animal, and the age at which IGF-1 is manipulated. In this study, we examined how alterations in IGF-1 levels at multiple stages of development and aging influence overall lifespan, healthspan, and pathology. Specifically, we investigated the effects of perinatal, post-pubertal, and late-adult onset IGF-1 deficiency using genetic and viral approaches in both male and female igf f/f C57Bl/6 mice. Our results support the concept that IGF-1 levels early during lifespan establish the conditions necessary for subsequent healthspan and pathological changes that contribute to aging. Nevertheless, these changes are specific for each sex and tissue. Importantly, late-life IGF-1 deficiency (a time point relevant for human studies) reduces cancer risk but does not increase lifespan. Overall, our results indicate that the levels of IGF-1 during development influence late-life pathology, suggesting that IGF-1 is a developmental driver of healthspan, pathology, and lifespan.Keywords
Funding Information
- National Institute on Aging (R01-AG038747, R01-AG047879, F32-AG048728)
- American Federation for Aging Research
- Ellison Medical Foundation
- Arkansas Claude Pepper Older Americans Independence Center (P30-AG028718)
- Oklahoma Center for the Advancement of Science and Technology
- San Antonio Nathan Shock Center
- Oklahoma Nathan Shock Center (P30-AG050911)
- Donald W. Reynolds Foundation
This publication has 55 references indexed in Scilit:
- Diverse Roles of Growth Hormone and Insulin-Like Growth Factor-1 in Mammalian Aging: Progress and ControversiesThe Journals of Gerontology: Series A, 2012
- Does Reduced IGF-1R Signaling in Igf1r+/− Mice Alter Aging?PLOS ONE, 2011
- Growth Hormone and IGF-1 Deficiency Exacerbate High-Fat Diet-Induced Endothelial Impairment in Obese Lewis Dwarf Rats: Implications for Vascular AgingThe Journals of Gerontology: Series A, 2011
- Liver-Specific Knockdown of IGF-1 Decreases Vascular Oxidative Stress Resistance by Impairing the Nrf2-Dependent Antioxidant Response: A Novel Model of Vascular AgingThe Journals of Gerontology: Series A, 2011
- Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous MiceThe Journals of Gerontology: Series A, 2010
- Reduced Incidence and Delayed Occurrence of Fatal Neoplastic Diseases in Growth Hormone Receptor/Binding Protein Knockout MiceThe Journals of Gerontology: Series A, 2009
- Functionally significant insulin-like growth factor I receptor mutations in centenariansProceedings of the National Academy of Sciences of the United States of America, 2008
- Childhood Growth and Hypertension in Later LifeHypertension, 2007
- Infant Growth and Stroke in Adult LifeStroke, 2007
- The effects of growth hormone and IGF‐1 deficiency on cerebrovascular and brain ageingJournal of Anatomy, 2000